Can nutrient status, exercise demand, and basic labs affect transsulfuration changes?

The claim is substantially correct: transsulfuration is sensitive to nutrient context and may not be reflected in routine laboratory testing. The strength of evidence differs across the proposed influences.

Metabolic and mechanistic evidence

• Substrate availability has direct human flux evidence. In controlled dual-tracer studies of healthy men, replacing dietary methionine with cysteine reduced transsulfuration from 7.8 to 2.8 and 1.5 μmol·kg⁻¹·h⁻¹. Sulfur-amino-acid deprivation likewise reduced transsulfuration, while cysteine supplementation reduced methionine oxidation. This supports substrate-dependent routing through the pathway, although extra cysteine does not necessarily increase erythrocyte glutathione when methionine intake is adequate.
• Vitamin B6 is a biologically credible, step-specific modifier. Pyridoxal phosphate is required by cystathionine γ-lyase. Controlled B6 restriction increased plasma cystathionine by 124%, consistent with reduced conversion of cystathionine downstream. Yet whole-body/postprandial transsulfuration, cysteine flux, and plasma cysteine were unchanged in controlled studies, so B6 status cannot be assumed to alter aggregate pathway flux in every setting.
• Exercise-related antioxidant demand is plausible but unproven as a flux driver. Exercise-associated changes in methionine, homocysteine, cystathionine, cysteine, glutathione, and taurine are compatible with antioxidant-related pathway recruitment, but may also result from hemoconcentration, redistribution, protein breakdown, or altered clearance.

Testing implications

• BMPs and CBCs do not measure cystathionine or other amino-acid intermediates, so normal basic panels cannot exclude transsulfuration-related biochemical changes. Quantitative plasma amino-acid testing can measure cystathionine; plasma total homocysteine is generally the usual first-line test when a relevant disorder is suspected.
• Urinary cystathionine requires targeted testing and can be informative, but interpretation depends on renal filtration/reabsorption, medications, and creatinine normalization; it is not a universal first-tier screen.

Bottom line

• Substrate effects are established; B6 and exercise are context-dependent plausible modifiers. Routine blood panels can miss these pathway-level signals, but targeted plasma homocysteine and amino-acid testing generally provide the most appropriate initial assessment.